Loading...

ANIP ANI PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

N PH

NP

ANI PHARMACEUTICALS INC

(ANIP)

2025 8-K

Show Summary

Summary

Financial Statements

Investor Meetings

Investor Meetings

Financial Statements

Rights Offerings

Royalty Buy-Out

Investor Presentation

Financial Results

Investor Presentation

Financial Results

Investor Presentation

Financial Results

Earnings Report

Acquisition Completed

Private Offering

Financial Results Announcement

Merger Agreement

Results of Operations and F...

Departure of Directors or C...

Panel Discussion at Biotech...

Financial Results Announcement

Investor Meeting

Investor Presentation

Financial Results Announcement

Agreement for Sale of Manuf...

Presentation at Conference

Investor Presentation

Presentation at Conference

Financial Results Announcement

Presentation at Conference

Presentation to Investors

Presentation to Investors

Appointment of Director

Financial Results Announcement

Investor Presentation

Annual Meeting Approval

Sale of Common Stock

Public Offering

Underwritten Equity Offering

Policy Amendment and Direct...

Earnings Reports

FDIC Control of SVB

Earnings Reports

Bylaws Amendments

External Links:

ANI Pharmaceuticals filed a proxy supplement on May 6, 2025, to clarify details related to their Amended and Restated 2022 Stock Incentive Plan, indicating a total of 1,177,800 shares remain for future grants as of March 24, 2025. As of that date, their stock was trading at $65.98 per share.

AI Assistant

ANI PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.